US study: A new blood analysis can reduce the failure of liver transplants

Researchers have concluded a study by the University of Georgetown, USA, that a blood analysis is still experimenting, surgeons can help to discover and identify problems in the newly implanted liver during the early stages. The new analysis depends on the capturing of the DNA parts left by dead cells in the blood, as the researchers indicated that the chemical fingerprints on these parts can be used to accurately determine the original cell type and location. The University of Georgetown has submitted a patent request for this technology, and the research team is currently trying to find partners to market the analysis. “If the affected part of the liver, such as bile ducts or blood vessels, can provide a more suitable therapeutic approach to the patient and lead to better care,” the Studies Team leader, Doctor Alexander Kromer of the ‘Medistar’ Hospital told Georgetown University. He added that “in addition to the blood analysis faster and less interfering than traditional biopsy, it is also possible to be more accurate, because the biops’ samples take, except from some parts of the liver and the problem of the problem may be wrong.” According to a recent published report in the Scientific Journal “Nature Communichens”, it is common for cultivated members and tissues near the bodies of the recipients that have damaged during the transplant.